XH0A57

ICD-11 MMS 2026-01

Water-clear cell adenocarcinoma

Index terms

  • Water-clear cell adenocarcinoma
  • Water-clear cell carcinoma

Inclusions

  • Water-clear cell carcinoma

Sibling codes

  • XH0349 – Adenocarcinoma, intestinal type
  • XH0426 – Papillary carcinoma, diffuse sclerosing
  • XH05V6 – Renal cell carcinoma, NOS
  • XH0718 – Endometrioid adenocarcinoma, secretory variant
  • XH07X3 – Alveolar adenocarcinoma
  • XH09B7 – Endometrioid cystadenocarcinoma
  • XH09D6 – Oxyphilic adenocarcinoma
  • XH0G90 – Hepatocellular carcinoma, pleomorphic type
  • XH0GS9 – Adenocarcinoma, endocervical type
  • XH0JE3 – Superficial spreading adenocarcinoma
  • XH0LH8 – Enterochromaffin-like cell tumour
  • XH0Q59 – Papillary carcinoma, encapsulated, of thyroid
  • XH0RU3 – Acquired cystic disease associated renal cell carcinoma
  • XH0SD2 – Endometrioid adenocarcinoma, NOS
  • XH0U20 – Neuroendocrine carcinoma, NOS
  • XH0VD1 – Follicular adenocarcinoma, trabecular
  • XH0X20 – Villous adenocarcinoma
  • XH0XL5 – Carcinoma, diffuse type
  • XH0Y80 – Follicular carcinoma, encapsulated, angioinvasive
  • XH1108 – Nonencapsulated sclerosing carcinoma
  • XH1442 – MiT Family translocation carcinomas
  • XH1D07 – Papillary renal cell carcinoma
  • XH1JZ0 – Parietal cell carcinoma
  • XH1ND9 – Papillary carcinoma of thyroid
  • XH1NL5 – Nesidioblastoma
  • XH1VB1 – Hybrid oncocytic chromophobe tumour
  • XH1YZ3 – Cribriform carcinoma, NOS
  • XH1Z69 – Typical carcinoid
  • XH2035 – Bronchiolo-alveolar carcinoma, non-mucinous
  • XH2098 – Minimally invasive adenocarcinoma, Mucinous
  • XH22Z8 – Carcinoma of Skene, Cowper and Littre Glands
  • XH24W2 – Lepidic adenocarcinoma
  • XH29M4 – Papillary carcinoma, follicular variant
  • XH2AM6 – Mixed cell adenocarcinoma
  • XH2AW7 – Papillary microcarcinoma
  • XH2EH4 – Granular cell carcinoma
  • XH2MW1 – Medullary carcinoma with amyloid stroma
  • XH2PF0 – Enteroglucagonoma
  • XH2Q13 – Clear cell adenocarcinofibroma
  • XH2QZ6 – Acidophil carcinoma
  • XH2ST7 – Islet cell tumor, NOS
  • XH2ZA2 – Bronchial adenoma, carcinoid
  • XH2ZH8 – Adenocarcinoma in adenomatous polyposis coli
  • XH2ZQ0 – Adenocarcinoma with mixed subtypes
  • XH3340 – Mixed medullary-papillary carcinoma
  • XH34G3 – Solid carcinoma with mucin formation
  • XH3614 – Islet cell adenocarcinoma
  • XH3709 – Pancreatic neuroendocrine tumor, nonfunctioning
  • XH3BU6 – Bile duct cystadenocarcinoma
  • XH3CU4 – Villoglandular variant of endometrioid adenocarcinoma
  • XH3DN7 – Follicular carcinoma, minimally invasive
  • XH3QM0 – Minimally invasive adenocarcinoma, Non-mucinous
  • XH3T17 – Hepatocellular carcinoma, spindle cell variant
  • XH3XT5 – Glycogen-rich carcinoma
  • XH3Z08 – Renal cell carcinoma, unclassified
  • XH3Z50 – Follicular carcinoma, NOS
  • XH41P2 – Endocrine tumour, functioning, NOS
  • XH4262 – Goblet cell carcinoid
  • XH4302 – Adenoid cystic carcinoma
  • XH43E4 – Perihilar cholangiocarcinoma
  • XH46F1 – Clear cell renal cell carcinoma, NOS
  • XH4BY1 – Islet cell adenoma
  • XH4FS4 – Scirrhous adenocarcinoma
  • XH4KH2 – Adrenal cortical carcinoma
  • XH4KK0 – Cyst-associated renal cell carcinoma
  • XH4MW7 – Micropapillary adenocarcinoma
  • XH4NH4 – Pituitary neuroendocrine tumour
  • XH4NQ8 – Glucagonoma
  • XH4PB1 – Acinar adenocarcinoma of prostate
  • XH4Q20 – Papillotubular adenocarcinoma
  • XH4SH8 – Insulinoma, NOS
  • XH4SQ4 – Collecting duct carcinoma
  • XH4T58 – Hepatocellular carcinoma, clear cell type
  • XH4TA4 – Tubular adenocarcinoma
  • XH4W48 – Hepatocellular carcinoma, NOS
  • XH4YG1 – Cribriform comedo-type carcinoma
  • XH4ZC3 – Basal cell carcinoma of the prostate
  • XH5085 – Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome-associated renal cell carcinoma
  • XH51K1 – Neuroendocrine tumour, grade 2
  • XH55D7 – Neuroendocrine carcinoma, well-differentiated
  • XH5761 – Hepatocellular carcinoma, scirrhous
  • XH5LA4 – Adenocarcinoid tumour
  • XH5P16 – Fetal adenocarcinoma
  • XH5QV8 – Pituitary blastoma
  • XH5QW8 – Neuroendocrine tumour, grade 3
  • XH5RE1 – Adenocarcinoma of anal glands
  • XH5TR7 – Adenocarcinoma of lung, mixed mucinous and non-mucinous
  • XH5VH0 – Somatostatinoma
  • XH5XB7 – Islet cell carcinoma
  • XH5YT2 – Papillary carcinoma, oncocytic variant
  • XH60V1 – Medullary thyroid carcinoma
  • XH6153 – Renal cell carcinoma, chromophobe type
  • XH6DA5 – Adenocarcinoma in villous adenoma
  • XH6H10 – Mixed adenoneuroendocrine carcinoma
  • XH6KR7 – Endometrioid adenofibroma, malignant
  • XH6L02 – Clear cell adenocarcinoma, NOS
  • XH6LF9 – Carcinoma simplex
  • XH6LV9 – Papillary adenocarcinoma, NOS
  • XH6QG3 – Micropapillary carcinoma, NOS
  • XH6TK0 – Lipid-rich carcinoma
  • XH6UP4 – Mixed endocrine and exocrine adenocarcinoma
  • XH6XY9 – Pancreatobiliary-type carcinoma
  • XH6YH5 – Hurthle cell adenocarcinoma
  • XH6YS0 – Clear cell adenocarcinoma, mesonephroid
  • XH7019 – Mixed acidophil-basophil carcinoma
  • XH7152 – Glucagon-like peptide-producing tumour
  • XH72E5 – Vipoma
  • XH74B2 – Serrated adenocarcinoma
  • XH74S1 – Adenocarcinoma, NOS
  • XH74Y9 – Mixed acinar-endocrine-ductal carcinoma
  • XH7AG8 – ACTH-producing tumour
  • XH7CY5 – Mixed ductal-endocrine carcinoma
  • XH7DG7 – Mixed medullary-follicular carcinoma
  • XH7EX3 – Trabecular adenocarcinoma
  • XH7F73 – Neuroendocrine carcinoma, moderately differentiated
  • XH7GY6 – Adenocarcinoma of lung, mucinous
  • XH7JQ0 – Parathyroid carcinoma
  • XH7K79 – Tubulocystic renal cell carcinoma
  • XH7KL6 – Pituitary carcinoma, NOS
  • XH7LW9 – L-cell tumour
  • XH7M15 – Cholangiocarcinoma
  • XH7NM1 – Enterochromaffin cell carcinoid
  • XH7QB1 – Adenocarcinoma in tubulovillous adenoma
  • XH7QJ6 – Combined hepatocellular carcinoma and cholangiocarcinoma
  • XH7QZ0 – Adenocarcinoma in adenomatous polyp
  • XH7SS7 – Chromophobe carcinoma
  • XH7TE3 – Follicular adenocarcinoma, moderately differentiated
  • XH81N8 – Merkel cell carcinoma
  • XH81Q9 – Bronchial adenoma, cylindroid
  • XH85C2 – Endolymphatic sac tumor
  • XH85E5 – Papillary carcinoma, columnar cell
  • XH8B45 – Solid carcinoma, NOS
  • XH8DS0 – Neuroendocrine tumour, NOS
  • XH8E54 – Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN)
  • XH8EN1 – Succinate dehydrogenase deficient renal cell carcinoma
  • XH8EZ3 – Mixed acinar-endocrine carcinoma
  • XH8FK7 – Follicular adenocarcinoma, well differentiated
  • XH8LX8 – Neuroendocrine carcinoma, low grade
  • XH8MQ3 – Hurthle cell carcinoma
  • XH8SF8 – Islet cell adenomatosis
  • XH8UE4 – Adenocarcinoma, metastatic, NOS
  • XH8VU6 – Poorly differentiated thyroid carcinoma
  • XH8WM4 – Linitis plastica
  • XH90N9 – Follicular carcinoma, oxyphilic cell
  • XH92Y9 – Thymic carcinoma with adenoid cystic carcinoma-like features
  • XH93H8 – Gastrinoma
  • XH9508 – Endometrioid adenocarcinoma, ciliated cell variant
  • XH95U1 – Villoglandular carcinoma
  • XH9DH7 – Renal cell carcinoma, sarcomatoid
  • XH9LV7 – Basophil carcinoma
  • XH9LV8 – Neuroendocrine tumor, grade 1
  • XH9LZ7 – Mixed pancreatic endocrine and exocrine tumour, malignant
  • XH9Q35 – Hepatocellular carcinoma, fibrolamellar
  • XH9SA7 – Basal cell adenocarcinoma
  • XH9YR3 – Adenocarcinoma in multiple adenomatous polyps
  • XH9ZS8 – Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumour

Foundation entity

Water-clear cell adenocarcinoma – http://id.who.int/icd/entity/614648657

Part of: X: Extension Codes